Grade evidence to decision (etd) framework for coverage decisions

International Journal of Technology Assessment in Health Care

Volumn 33, Issue 2, 2017, Pages 176-182

  Parmelli, Elena ^a   Amato, Laura ^b   Oxman, Andrew D ^c   Alonso Coello, Pablo ^d   Brunetti, Massimo ^e   Moberg, Jenny ^f   Nonino, Francesco ^g   Pregno, Silvia ^e   Saitto, Carlo ^h   Schünemann, Holger J ^d   Davoli, Marina ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d MCMASTER UNIVERSITY   (Canada)

^e Local Health Authority   (Italy)

^f NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^g WHO Collaborating Centre for Evidence Based Research Synthesis and Guidelines Development   (Italy)

^h Department of Epidemiology   (Italy)

Author keywords

Coverage decisions; GRADE

Indexed keywords

COST EFFECTIVENESS; ECONOMIC AND SOCIAL EFFECTS; GRADING; ITERATIVE METHODS;

COMMUNICATION STRATEGY; COVERAGE DECISIONS; DECISION MAKING PROCESS; GENERAL STRUCTURES; INFORMED DECISION; ITERATIVE APPROACH; PRICE NEGOTIATIONS; WORKING GROUPS;

DECISION MAKING;

BRAINSTORMING; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; UNCERTAINTY; EUROPEAN UNION; EVIDENCE BASED MEDICINE; HUMAN; INTERPERSONAL COMMUNICATION;

COMMUNICATION; DECISION MAKING; EUROPEAN UNION; EVIDENCE-BASED MEDICINE; HUMANS; JUDGMENT;

EID: 85021390016     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462317000447     Document Type: Article

References (29)

1. Fischer KE. A systematic review of coverage decision-making on health technologies-evidence from the real world. Health Policy. 2012;107:218-230.
2. Guindo LA, Wagner M, Baltussen R, et al. From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking. Cost Eff Resour Alloc. 2012;10:9.
3. Henshall C, Schuller T, Mardhani-Bayne L. Using health technology assessment to support optimal use of technologies in current practice: The challenge of "disinvestment". Int J Technol Assess Health Care. 2012;28:203-210.
4. Tromp N, Baltussen R. Mapping of multiple criteria for priority setting of health interventions: An aid for decision makers. BMC Health Serv Res. 2012;12:454.
5. Tony M, Wagner M, Khoury H, et al. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): Field testing of the EVIDEM framework for coverage decisions by a public payer in Canada. BMC Health Serv Res. 2011;11:329.
6. Harris AH, Hill SR, Chin G, Li JJ, Walkom E. The role of value for money in public insurance coverage decisions for drugs in Australia: A retrospective analysis 1994-2004. Med Decis Making. 2008;28: 713-722.
7. Ottersen TNO, Chitah BM, Cookson R, Daniels N, et al. Making fair choices on the path to universal health coverage. Final report of the WHO Consultative Group on Equity and Universal Health Coverage. Geneva: WHO; 2014.
8. Faunce TA. Challenges for Australia's bio/nanopharma policies: Trade deals, public goods and reference pricing in sustainable industrial renewal. Aust New Zealand Health Policy. 2007;4:9.
9. Daniels N. Accountability for reasonableness. BMJ. 2000;321:1300-1301.
10. Alonso-Coello P, Oxman AD, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016;353:i2089.
11. Alonso-Coello P, Schünemann HJ, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016;353:i2016.
12. Treweek S, Oxman AD, Alderson P, et al. Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): Protocol and preliminary results. Implement Sci. 2013;8:6.
13. Schünemann HJ, Mustafa R, Brozek J, et al. GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. J Clin Epidemiol. 2016;76:89-98.
14. Claxton K, Martin S, Soares M, et al. Methods for the estimation of the National Institute for Health and Care Excellence cost effectiveness threshold. Health Technol Assess. 2013;19:1-503.
15. Rocchi A, Menon D, Verma S, Miller E. The role of economic evidence in Canadian oncology reimbursement decision-making: To lambda and beyond. Value Health. 2008;11:771-783.
16. Drummond MF, Schwartz JS, Jonsson B, et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244-258; discussion 362-368.
17. Levin L, Goeree R, Levine M, et al. Coverage with evidence development: The Ontario experience. Int J Technol Assess Health Care. 2011;27:159-168.
18. Hutton J, Trueman P, Henshall C. Coverage with evidence development: An examination of conceptual and policy issues. Int J Technol Assess Health Care. 2007;23:425-432.
19. Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;1:CD004720.
20. Heijnsdijk EA, Wever EM, Auvinen A, et al. Quality-of-life effects of prostate-specific antigen screening. N Engl J Med. 367;367:595-605.
21. Djulbegovic M, Beyth RJ, Neuberger MM, et al. Screening for prostate cancer: Systematic review and meta-analysis of randomised controlled trials. BMJ. 2010;341:c4543.
22. de Bekker-Grob EW, Rose JM, Donkers B, et al. Men's preferences for prostate cancer screening: A discrete choice experiment. Br J Cancer. 2013;108:533-541.
23. Drummond M. Twenty years of using economic evaluations for drug reimbursement decisions:What has been achieved? J Health Polit Policy Law. 2013;38:1081-1102.
24. Dakin H, Devlin N, Feng Y, Rice N, O'Neill P, Parkin D. The influence of cost-effectiveness and other factors on nice decisions. Health Econ. 2014 [Epub ahead of print].
25. Jefferson T, Demicheli V. Quality of economic evaluations in health care. BMJ. 2002;324:313-314.
26. Brunetti M, Shemilt I, Pregno S, et al. GRADE guidelines 10. Considering resource use and rating the quality of economic evidence. J Clin Epidemiol. 2013;66:140-150.
27. Garrison LP Jr, Towse A, Briggs A, et al. Performance-based risksharing arrangements-good practices for design, implementation, and evaluation: Report of the ISPOR good practices for performance-based risk-sharing arrangements task force. Value Health. 2013;16:703-719.
28. Neumann I, Brignardello-Petersen R, Wiercioch W, et al. The GRADE evidence-to-decision framework: A report of its testing and application in 15 international guideline panels. Implement Sci. 2016;11:93.
29. Gonzalez-LorenzoM, Piatti A, Coppola L, et al. Conceptual frameworks and key dimensions to support coverage decisions for vaccines. Vaccine. 2015;33:1206-1217.